These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2898961)

  • 1. The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
    Jones BJ; Costall B; Domeney AM; Kelly ME; Naylor RJ; Oakley NR; Tyers MB
    Br J Pharmacol; 1988 Apr; 93(4):985-93. PubMed ID: 2898961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly potent inhibitory effects of 5-HT3 receptor antagonist, GR38032F, on non-opioid defeat analgesia in male mice.
    Rodgers RJ; Shepherd JK; Randall JI
    Neuropharmacology; 1990 Jan; 29(1):17-23. PubMed ID: 2137563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
    Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Oakley NR; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1989 Dec; 34(4):769-78. PubMed ID: 2576143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychopharmacology of 5-HT3 receptors.
    Costall B; Naylor RJ; Tyers MB
    Pharmacol Ther; 1990; 47(2):181-202. PubMed ID: 2203069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats.
    Goudie AJ; Leathley MJ
    Eur J Pharmacol; 1990 Aug; 185(2-3):179-86. PubMed ID: 1979273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
    Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
    Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.
    Hagan RM; Butler A; Hill JM; Jordan CC; Ireland SJ; Tyers MB
    Eur J Pharmacol; 1987 Jun; 138(2):303-5. PubMed ID: 2442006
    [No Abstract]   [Full Text] [Related]  

  • 11. [The anxiolytic effect of ondansetron and its capacity to eliminate the benzodiazepine abstinence syndrome in rats].
    Garibova TL; Voronina TA; Kraĭneva VA; Val'dman EA
    Eksp Klin Farmakol; 1999; 62(6):16-9. PubMed ID: 10650519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig.
    Costall B; Gunning SJ; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Jun; 91(2):263-4. PubMed ID: 2955843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic potential of 5-HT3 receptor antagonists.
    Costall B; Naylor RJ
    Pharmacol Toxicol; 1992 Mar; 70(3):157-62. PubMed ID: 1349746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a novel 5-hydroxytryptamine3-antagonist, GR38032F, on the 5-hydroxytryptamine-induced increase in carotid sinus nerve activity in rats.
    Yoshioka M
    J Pharmacol Exp Ther; 1989 Aug; 250(2):637-41. PubMed ID: 2527299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose ranging phase I study of the serotonin antagonist GR38032F for prevention of cisplatin-induced nausea and vomiting.
    Grunberg SM; Stevenson LL; Russell CA; McDermed JE
    J Clin Oncol; 1989 Aug; 7(8):1137-41. PubMed ID: 2526864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 5-hydroxytryptamine on external carotid nerve activity and its blockade by GR38032F in anesthetized rats.
    Yoshioka M; Ikeda T; Abe M; Togashi H; Saito H
    Res Commun Chem Pathol Pharmacol; 1991 Oct; 74(1):39-45. PubMed ID: 1839326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-HT3 receptor antagonists ICS 205-930 and GR38032F, putative anxiolytic drugs, differ from diazepam in their pharmacological profile.
    Papp M; Przegalinski E
    J Psychopharmacol; 1989 Jan; 3(1):14-20. PubMed ID: 22156306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model.
    Roychoudhury M; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1997 Mar; 19(2):107-11. PubMed ID: 9151286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of 5-hydroxytryptamine-induced excitation of afferent cervical vagus nerve in anaesthetized rats.
    Yoshioka M; Ikeda T; Abe M; Togashi H; Minami M; Saito H
    Br J Pharmacol; 1992 Jul; 106(3):544-9. PubMed ID: 1387026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ondansetron on gastric emptying in the conscious rat.
    Forster ER; Dockray GJ
    Eur J Pharmacol; 1990 Nov; 191(2):235-8. PubMed ID: 2150819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.